Media Framing of Ozempic and Other GLP-1 Receptor Agonists in The New York Times
McMaster University Journal of Public Health · 2026
DOI: 10.15173/mujph.v3i2.4071 ↗Kurz gefasst
Fachartikel in der Zeitschrift McMaster University Journal of Public Health, 2026. Verfasst von Kevin Sogoli und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The rapid rise of GLP-1 based drugs, particularly Ozempic, has reshaped public perception surrounding weight loss drugs and its intended use. Media coverage of these drugs has played a critical role in influencing public opinion, however little research has been done to examine how portrayal of GLP-1 based drugs has evolved in media over time. This study analyzes how the news outlet The New York Times has framed the weight loss drugs Ozempic, Wegovy, Mounjaro, and Saxenda between 2022 to 2025, using a mixed method content analysis approach. Articles were collected through database and internal search engines and coded across six framing categories grouped under an analytical/evidence-based and lifestyle/human-interest based umbrella. Statistical tests were conducted to quantitatively analyze the shift in publication trends and thematic framing over time across these weight loss drugs. Results showed a large increase in Ozempic related coverage in 2023, with a shift toward lifestyle oriented framing which pushed more celebrity, lifestyle and trend narratives. In contrast, Saxenda, Wegovy, and Mounjaro were primarily portrayed in medical and clinical frames, illustrating that they have not yet entered pop culture. Correlation analyses indicated strong associations between Ozempic and aesthetic, empowerment, and trend themes, suggesting a cultural perception reframing around Ozempic distinct from other weight loss drugs. These findings detail how media portrayal can shift medical treatments into cultural frames, reshaping public perception and usage patterns of these weight loss drugs.
Zitieren
APA
Sogoli, K., Alasti, B., Vo, A., Yan, J., & Kalaikumar, A. (2026). Media Framing of Ozempic and Other GLP-1 Receptor Agonists in The New York Times. McMaster University Journal of Public Health. https://doi.org/10.15173/mujph.v3i2.4071
Vancouver
Sogoli K, Alasti B, Vo A, Yan J, Kalaikumar A. Media Framing of Ozempic and Other GLP-1 Receptor Agonists in The New York Times. McMaster University Journal of Public Health. 2026. doi:10.15173/mujph.v3i2.4071
BibTeX
@article{Sogoli2026,
author = {Sogoli, Kevin and Alasti, Bahar and Vo, Angeline and Yan, Jacklyn and Kalaikumar, Adrian},
title = {Media Framing of Ozempic and Other GLP-1 Receptor Agonists in The New York Times},
journal = {McMaster University Journal of Public Health},
year = {2026},
doi = {10.15173/mujph.v3i2.4071}
}
EUVIMED